These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 26545798
1. Discovery of bis-aryl urea derivatives as potent and selective Limk inhibitors: Exploring Limk1 activity and Limk1/ROCK2 selectivity through a combined computational study. Cui J, Ding M, Deng W, Yin Y, Wang Z, Zhou H, Sun G, Jiang Y, Feng Y. Bioorg Med Chem; 2015 Dec 01; 23(23):7464-77. PubMed ID: 26545798 [Abstract] [Full Text] [Related]
2. Discovery of potent and selective urea-based ROCK inhibitors: Exploring the inhibitor's potency and ROCK2/PKA selectivity by 3D-QSAR, molecular docking and molecular dynamics simulations. Mei D, Yin Y, Wu F, Cui J, Zhou H, Sun G, Jiang Y, Feng Y. Bioorg Med Chem; 2015 May 15; 23(10):2505-17. PubMed ID: 25882521 [Abstract] [Full Text] [Related]
3. Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors. Yin Y, Zheng K, Eid N, Howard S, Jeong JH, Yi F, Guo J, Park CM, Bibian M, Wu W, Hernandez P, Park H, Wu Y, Luo JL, LoGrasso PV, Feng Y. J Med Chem; 2015 Feb 26; 58(4):1846-61. PubMed ID: 25621531 [Abstract] [Full Text] [Related]
4. Design, synthesis and biological characterization of selective LIMK inhibitors. Boland S, Bourin A, Alen J, Geraets J, Schroeders P, Castermans K, Kindt N, Boumans N, Panitti L, Vanormelingen J, Fransen S, Van de Velde S, Defert O. Bioorg Med Chem Lett; 2015 Sep 15; 25(18):4005-10. PubMed ID: 26233434 [Abstract] [Full Text] [Related]
5. Design, synthesis, and biological evaluation of urea-based ROCK2 inhibitors. Wang L, Qi J, Fan M, Yao L. Chem Biol Drug Des; 2021 Dec 15; 98(6):969-978. PubMed ID: 34581498 [Abstract] [Full Text] [Related]
7. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations. Shen M, Zhou S, Li Y, Pan P, Zhang L, Hou T. Mol Biosyst; 2013 Mar 15; 9(3):361-74. PubMed ID: 23340525 [Abstract] [Full Text] [Related]
15. Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization. Champiré A, Berabez R, Braka A, Cosson A, Corret J, Girardin C, Serrano A, Aci-Sèche S, Bonnet P, Josselin B, Brindeau P, Ruchaud S, Leguevel R, Chatterjee D, Mathea S, Knapp S, Brion R, Verrecchia F, Vallée B, Plé K, Bénédetti H, Routier S. Eur J Med Chem; 2024 May 05; 271():116391. PubMed ID: 38669909 [Abstract] [Full Text] [Related]
16. Molecular modeling studies of Rho kinase inhibitors using molecular docking and 3D-QSAR analysis. Qin J, Lei B, Xi L, Liu H, Yao X. Eur J Med Chem; 2010 Jul 05; 45(7):2768-76. PubMed ID: 20347188 [Abstract] [Full Text] [Related]
17. Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening. Chong CM, Kou MT, Pan P, Zhou H, Ai N, Li C, Zhong HJ, Leung CH, Hou T, Lee SM. Mol Biosyst; 2016 Aug 16; 12(9):2713-21. PubMed ID: 27354305 [Abstract] [Full Text] [Related]
18. Multi-objective Optimization of Benzamide Derivatives as Rho Kinase Inhibitors. Cardoso Gajo G, Rodrigues Silva D, Barigye SJ, da Cunha EFF. Mol Inform; 2018 Mar 16; 37(3):. PubMed ID: 28876533 [Abstract] [Full Text] [Related]